VEGFA and colonic neoplasm: In colon cancer (CRC) cells, miR-107 was identified as a direct wtp53 target that suppresses HIF1β expression and inhibits hypoxia-induced angiogenesis through blocking of vascular endothelial growth factor (VEGF) secretion [91].